Phase II Trial to Assess Safety and Immunogenicity of IMVAMUNE®

NCT01827371 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

435

Enrollment

NIH

Sponsor class

Conditions

Smallpox

Interventions

BIOLOGICAL: MVA Smallpox Vaccine

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)